Drug Type Small molecule drug |
Synonyms FX-006 |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1981), |
Regulation- |
Molecular FormulaC26H33FO7 |
InChIKeyVOBDXTSTTMAKHK-VHDCPBDGSA-N |
CAS Registry3870-07-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dermatitis, Atopic | CN | 01 Jan 1981 | |
Dermatitis, Seborrheic | CN | 01 Jan 1981 | |
Eczema | CN | 01 Jan 1981 | |
Neurodermatitis | CN | 01 Jan 1981 | |
Pruritus | CN | 01 Jan 1981 |
Phase 2 | 22 | xmhqalblam(nhxttaqwor) = mdubpxpayf gehmrehnlh (uqaocnbzfh, tndjbzrwbt - hbmyodiivp) View more | - | 02 Jan 2024 | |||
Phase 2 | 19 | (FX006 32mg in Glenohumeral OA Population) | fpptqfiqas(dpqwvdftgo) = kjundlsgsz bcmagsbwih (qqsdaqkzsu, znunkvegsi - xsiojuobpb) View more | - | 30 Nov 2021 | ||
(Normal Saline in Glenohumeral OA Population) | fpptqfiqas(dpqwvdftgo) = faxmabvtct bcmagsbwih (qqsdaqkzsu, lhgzngxqzy - nhmhkntrzt) View more | ||||||
Phase 3 | - | Suprachoroidal injection of CLS-TA | fclacfdfsp(kykybleifw) = yutmwvvktj qnsyqlqcng (npmqzohahq ) View more | - | 13 Nov 2021 | ||
misrykxrtb(kshrmygicl) = spuvriysei xjhxtlyfbo (ahonsniaww ) View more | |||||||
Phase 3 | 325 | suprachoroidal CLS-TA+Lucentis or Avastin (Active) | lzabomdcps(dzvkwwcugu) = dbraiqtsfz rnxdgcixzp (uprxkrxyab, lucpighrtm - ldenxtfrjf) View more | - | 23 Apr 2021 | ||
suprachoroidal sham+Lucentis or Avastin (Control) | lzabomdcps(dzvkwwcugu) = riviackeav rnxdgcixzp (uprxkrxyab, cbtilqqseo - gphnwxwdyt) View more | ||||||
Phase 3 | 460 | (Active) | ucsdypxxej(bkgsormppr) = nfvljtvlnr zzogwktzns (afjdqqvftd, wnpywjclzn - mnqzhpbwbs) View more | - | 14 Apr 2021 | ||
suprachoroidal sham+IVT aflibercept (Control) | ucsdypxxej(bkgsormppr) = yqhxnabadx zzogwktzns (afjdqqvftd, mixzenguqp - oqdmpzwgvw) View more | ||||||
Phase 2 | 16 | xjwbnjymwj(seihhwxztt) = mbifodozit tksoyaexst (ydcpnkpawl, yfxifjahff - teojogxkrq) View more | - | 01 Dec 2020 | |||
Phase 3 | 70 | (FX006) | rfwbxlwajz(eucxeudeuo) = vlkwkvcltm jihnqitzns (subljvmvub, hdwbbizzdu - jzedpbfknm) View more | - | 14 Sep 2020 | ||
(Normal Saline) | rfwbxlwajz(eucxeudeuo) = hvjofdycew jihnqitzns (subljvmvub, pkerngqdjj - vyhnaazstd) View more | ||||||
Phase 2 | 55 | (FX006 32 mg Shoulder) | hqijzjkgrq(odrbynafkb) = wuyiuixkfn gwlmnmuaog (ogydcchvjm, fbfqhmmzbk - cppylkiwst) View more | - | 09 Dec 2019 | ||
TAcs (TAcs 40 mg Shoulder) | hqijzjkgrq(odrbynafkb) = crlboxnomm gwlmnmuaog (ogydcchvjm, lywmwhmyxz - rvrknlzkwk) View more | ||||||
Phase 2 | 24 | (FX006 10mg) | wmxtyfmgzz(qexoaursvk) = gfudmwvtzw ieheobregy (aguhhatriz, nkbnuotpnj - meoyhysqez) View more | - | 06 Dec 2019 | ||
(FX006 40mg) | wmxtyfmgzz(qexoaursvk) = qangridwvf ieheobregy (aguhhatriz, kclqyktecw - xkuclzwiin) View more | ||||||
Phase 3 | 208 | ownrkvcmez(qhbvonncfo) = ykjaynlzzq wvmfwpzjld (wkoxohmetu, gcvxbmjlax - tzfvgnpequ) View more | - | 29 Oct 2019 |